ACT

CAPScall of the Week: Intercept Pharmaceuticals

For years, satirical late-night TV host Stephen Colbert has been running a series on his show called “Better Know a District,” which highlights one of the 435 U.S. congressional districts and its representative. While I am no Stephen Colbert, I ;am ;brutally inquisitive when it comes to the 5,000-plus listed companies on the U.S. stock exchanges.That’s why I’ve made it […]

Sterne Agee Dives Deep Into 3 Biotechs

View photo.Biotech stocks have performed well in the recent bull market.Since January 1, 2008, the SPDR S&P Biotech ETF (NYSE: XBI) has outperformed the SPDR S&P 500 ETF Trust (NYSE: SPY), gaining 233 percent compared with just 41.3 percent gains in SPY.Analysts at Sterne Agee took a closer look at three active biotech companies in separate notes Friday morning.Molina Healthcare, […]

Stock Market News for February 10, 2015 – Zacks Investment …

Markets ended in negative territory for second-consecutive day as intensified concern about Greece’s debt negotiations continued to hurt investor sentiment. Moreover, China’s disappointing trade data also had a negative impact on benchmarks on Monday. However, rise in oil prices limited some of the day’s losses.For a look at the issues currently facing the markets, make sure to read today’s Ahead […]

Wall St. inches up in short session, indexes at records

Wall St. inches up in short session, indexes at recordsBy Ryan VlastelicaNEW YORK Wed Dec 24, 2014 11:41am EST

Share this

Email
Print
The exterior of the New York Stock Exchange is pictured with a Christmas tree in front of it in the Manhattan Borough of New York, December 23, 2014. U.S. stocks advanced on Tuesday, as the Dow climbed above the 18,000 mark […]

Actavis upgraded at RBC Capital

moreView todays social media effects on ACTView the latest stocks trending across Twitter. Click to view dashboardSee who Actavis is hiring next, click here to view […]

Actavis Announces Acanya® Gel Patent Challenge Settlement

[PR Newswire] – DUBLIN, May 12, 2014 /PRNewswire/ — Actavis plc (ACT) today announced that it has entered into an agreement with Valeant Pharmaceuticals International to settle all outstanding patent litigation related to Actavis’ generic version of Aca moreView todays social media effects on ACTView the latest stocks trending across Twitter. Click to view dashboardSee who Actavis is hiring next, […]

ACTAVIS PLC Financials

moreView todays social media effects on ACTView the latest stocks trending across Twitter. Click to view dashboardSee who Actavis is hiring next, click here to view […]

Vivus Discloses Competitive Threat

moreView todays social media effects on ACTView the latest stocks trending across Twitter. Click to view dashboardSee who Actavis is hiring next, click here to view […]